- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 29.09. | Neurocrine Biosciences Welcomes Back Eiry Roberts as Chief Medical Officer | ||
| 29.09. | ESTEVE CDMO Invests Additional $17.5M in Illinois Site | ||
| 29.09. | Forge, TECPR2 Research Foundation Strike AAV Gene Therapy Development, Manufacturing Partnership | ||
| 29.09. | Evotec Searches for New Chief Scientific Officer | ||
| 29.09. | Genentech Breaks Ground on $750M Expansion in Hillsboro, Oregon | ||
| 29.09. | AstraZeneca Makes $2B Equity Investment in Summit Therapeutics | ||
| 29.09. | Quotient, Acesion Partner on AI Drug Development | ||
| 29.09. | Almac Appoints Cheryl Kole as President and Managing Director | ||
| 29.09. | Axplora Expands Exatecan Options for ADC Developers | ||
| 29.09. | Novo Nordisk Signs $2.6B Hengrui Oral GLP-1 Deal | ||
| 29.09. | Serán Bioscience Secures Growth Investment | ||
| 28.09. | Circle Pharma Makes Two Executive Team Announcements | ||
| 28.09. | Lilly's Olumiant OKed by FDA for Pediatric Patients Over 12 with Severe Alopecia Areata | ||
| 28.09. | Thermo Fisher Launches Nicolet RaptIR X FTIR Microscope | ||
| 28.09. | FDA Approves AbbVie's Juvmo for Parkinson's Disease | ||
| 28.09. | Gates Foundation Extends Funding for AN2 Therapeutics, GSK Research Collab | ||
| 28.09. | Eutecma Buys Tempaid in Cold Chain Packaging Deal | ||
| 28.09. | AGC Biologics to Manufacture Flen Health Wound-Care Enzymes | ||
| 28.09. | Vetter Expands Fill-Finish Capacity | ||
| 25.09. | Contract Pharma 2026 Conference Concludes with Risk Management Forum | ||
| 25.09. | SK pharmteco Launches Catalyst Kit | ||
| 25.09. | Recipharm, CanVirex Partner on Oncolytic Virus Manufacturing | ||
| 23.09. | Cellares, SNUH Partner on Cell Therapy Manufacturing | ||
| 23.09. | AustinPx KinetiSol Earns FDA AMT Designation | ||
| 23.09. | Contract Pharma Announces New Bio Outsourcing Conference in Cambridge |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.